Li Xuan

14PUBLICATIONS
37CO-AUTHORS
Infant and child healthHaematologyHaematological tumoursTraditional Chinese medicine and treatmentsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 27, 2025
Paediatric-inspired regimen reduces central nervous system relapse in adult acute lymphoblastic leukaemia.

Haimei Liang, Bailin He, Junjie Chen

|May 28, 2025
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial.

Yu Zhang, Zinan Feng, Jing Du

|May 21, 2025
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study.

Yiling Ye, Xinyu Liu, Huajuan Dai

|Nov 16, 2024
A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph+ acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study.

Hui Liu, Hui Xu, Peiru Chi

|Nov 12, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study.

Guopan Yu, Yu Zhang, Sijian Yu

|Apr 19, 2024
STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B-cell acute lymphoblastic leukaemia.

Xiuli Xu, Zicong Huang, Chenhao Ding

Pageof 3

Frequent Collaborators

14 joint publications

Qifa Liu

4 joint publications

Guopan Yu

4 joint publications

Zhixiang Wang

4 joint publications

Hua Jin